Tokai Pharmaceuticals
Tokai Pharmaceuticals is dedicated to developing innovative therapies for cancer patients, with a focus on prostate cancer and other hormonally-driven diseases. Their lead drug candidate, galeterone, is being evaluated in clinical trials for its effectiveness in treating castration-resistant prostate cancer by disrupting androgen receptor signaling.
Tokai Pharmaceuticals
Portfolio
Ablaze Pharmaceuticals is part of Vivo Capital's portfolio, focusing on innovative healthcare solutions.
#Pharmaceuticals
Aligos Therapeutics is involved in developing therapies for liver diseases and viral infections.
#Biopharmaceuticals
Actelion focuses on innovative treatments for pulmonary arterial hypertension.
#Biopharmaceuticals
Lepu Biopharma focuses on oncology therapeutics and successfully listed on the HKEX.
#Biopharmaceuticals
Lepu ScienTech focuses on interventional medical devices for structural heart disease and has a significant market share in China.
#Medical Technology